Edit Entry

Sarah Akerman, MD

Adjunct Assistant Professor of Psychiatry


MD, University of Miami Miller School of Medicine
BA, Tufts University

Selected Publications:


Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism.
Nunes EV, Bisaga A, Krupitsky E, Nangia N, Silverman BL, Akerman SC, Sullivan MA
Addiction. 2019 Jul 17; doi: 10.1111/add.14735. Epub 2019 Jul 17.
PMID: 31313402

Psychoeducational Strategies During Outpatient Transition to Extended-Release Naltrexone for Patients With Opioid Use Disorder.
Zavod A, Akerman SC, Snow MM, Tierney M, Sullivan MA
J Am Psychiatr Nurses Assoc. 2019 Jul/Aug;25(4):272-279. doi: 10.1177/1078390318820124. Epub 2018 Dec 20.
PMID: 30569814

Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence".
Silverman B, Bloomgren G, Jain P, Marcopul K, Silveira A, Fratantonio J, Sullivan M, Akerman S
Drug Saf. 2018 Oct;41(10):991-993. doi: 10.1007/s40264-018-0691-x.
PMID: 29956220

Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.
Bisaga A, Mannelli P, Yu M, Nangia N, Graham CE, Tompkins DA, Kosten TR, Akerman SC, Silverman BL, Sullivan MA
Drug Alcohol Depend. 2018 Jun 1;187:171-178. doi: 10.1016/j.drugalcdep.2018.02.023. Epub 2018 Apr 10.
PMID: 29674251

Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry.
Saxon AJ, Akerman SC, Liu CC, Sullivan MA, Silverman BL, Vocci FJ
Addiction. 2018 Aug;113(8):1477-1487. doi: 10.1111/add.14199. Epub 2018 Apr 1.
PMID: 29493836

Antagonist Treatment for Opioid Use Disorder.
Silverman BL, Akerman SC
Am J Med. 2017 Mar;130(3):e117. doi: 10.1016/j.amjmed.2016.08.048.
PMID: 28215953

An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorder.
Brunette MF, Akerman SC, Dawson R, O'Keefe CD, Green AI
Alcohol. 2016 Jun;53:45-50. doi: 10.1016/j.alcohol.2016.02.006. Epub 2016 Mar 17.
PMID: 27256763

A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report.
Goodman DJ, Milliken CU, Theiler RN, Nordstrom BR, Akerman SC
J Dual Diagn. 2015;11(3-4):248-57. doi: 10.1080/15504263.2015.1104484.
PMID: 26457976

Expanding Cessation Pharmacotherapy Via Videoconference Educational Outreach to Prescribers.
Brunette MF, Dzebisashvili N, Xie H, Akerman S, Ferron JC, Bartels S
Nicotine Tob Res. 2015 Aug;17(8):960-7. doi: 10.1093/ntr/ntv006.
PMID: 26180220

Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.
Akerman SC, Brunette MF, Green AI, Goodman DJ, Blunt HB, Heil SH
J Subst Abuse Treat. 2015 May;52:40-7. doi: 10.1016/j.jsat.2014.12.002. Epub 2014 Dec 22.
PMID: 25592332

View more publications on PubMed